NO20042389L - Anvendelse av en forbindelse ved behandling av sovnforstyrrelser og lignende ved a skaffe til veie utvilthet ved oppvakning og en fremgangsmate for behandling av omtakethet som er forbundet med dette - Google Patents

Anvendelse av en forbindelse ved behandling av sovnforstyrrelser og lignende ved a skaffe til veie utvilthet ved oppvakning og en fremgangsmate for behandling av omtakethet som er forbundet med dette

Info

Publication number
NO20042389L
NO20042389L NO20042389A NO20042389A NO20042389L NO 20042389 L NO20042389 L NO 20042389L NO 20042389 A NO20042389 A NO 20042389A NO 20042389 A NO20042389 A NO 20042389A NO 20042389 L NO20042389 L NO 20042389L
Authority
NO
Norway
Prior art keywords
awakening
treating
compound
treatment
providing
Prior art date
Application number
NO20042389A
Other languages
English (en)
Norwegian (no)
Inventor
Palaniswamy Sunderraj
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of NO20042389L publication Critical patent/NO20042389L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
NO20042389A 2001-11-30 2004-06-08 Anvendelse av en forbindelse ved behandling av sovnforstyrrelser og lignende ved a skaffe til veie utvilthet ved oppvakning og en fremgangsmate for behandling av omtakethet som er forbundet med dette NO20042389L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0128674.9A GB0128674D0 (en) 2001-11-30 2001-11-30 Treatment of sleep disorders and the like
US10/305,354 US20030134878A1 (en) 2001-11-30 2002-11-27 Use of a compound in providing refreshedness on waking and a method for the treatment of drowsiness therewith
PCT/GB2002/005427 WO2003047580A1 (en) 2001-11-30 2002-12-02 Use of a compound in the treatment of sleep disorders and the like, in providing refreshedness on waking and a method for the treatment of grogginess therewith

Publications (1)

Publication Number Publication Date
NO20042389L true NO20042389L (no) 2004-06-08

Family

ID=9926729

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20042389A NO20042389L (no) 2001-11-30 2004-06-08 Anvendelse av en forbindelse ved behandling av sovnforstyrrelser og lignende ved a skaffe til veie utvilthet ved oppvakning og en fremgangsmate for behandling av omtakethet som er forbundet med dette

Country Status (13)

Country Link
US (4) US20030134878A1 (zh)
EP (1) EP1455786A1 (zh)
JP (1) JP2005515200A (zh)
CN (1) CN1617723A (zh)
AU (2) AU2002350897B2 (zh)
CA (1) CA2468044A1 (zh)
GB (3) GB0128674D0 (zh)
IL (1) IL162146A0 (zh)
NO (1) NO20042389L (zh)
PL (1) PL370258A1 (zh)
RU (1) RU2320340C2 (zh)
WO (1) WO2003047580A1 (zh)
ZA (1) ZA200404172B (zh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0312425D0 (en) * 2003-05-30 2003-07-09 Boots Co Plc Use of a compound in the treatment of sleep disorders and the like,in providing refreshedness on waking and a method for the treatment of grogginess therewith
DE10332486A1 (de) * 2003-07-16 2005-02-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol für die Behandlung akuter Schmerzen
SG146631A1 (en) * 2003-09-03 2008-10-30 Novartis Ag Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep
CN101039664A (zh) * 2004-10-14 2007-09-19 大金工业株式会社 气氛改变方法、用于该气氛改变方法的喷雾剂与喷雾装置
JP2006137748A (ja) * 2004-10-14 2006-06-01 Daikin Ind Ltd 雰囲気改変方法、並びに、それに用いられる噴霧剤及び噴霧装置
US20070166336A1 (en) * 2005-12-13 2007-07-19 David Delmarre Stable and palatable oral liquid sumatriptan compositions
US20070299127A1 (en) * 2006-06-23 2007-12-27 The Procter & Gamble Company Compositions and kits comprising a melatonin component and an omega-3-fatty acid component
WO2008073961A2 (en) * 2006-12-12 2008-06-19 Emory University Compounds and methods for modulating the silencing of a polynucleotide of interest
AU2008326386B2 (en) * 2007-11-21 2014-07-31 The Procter & Gamble Company Preparations, methods and kits useful for treatment of cough
US20110065655A1 (en) * 2009-09-17 2011-03-17 Karry Whitten Therapeutic composition to treat lesions caused by herpes simplex virus
PL3273952T3 (pl) 2015-03-26 2022-11-14 SEN-JAM Pharmaceutical LLC Kombinacja naproksenu i feksofenadyny w celu zahamowania objawów związanych z zatruciem alkoholem
GR1010679B (el) * 2023-02-03 2024-04-26 Ιουλια Κλεωνος Τσετη Φαρμακευτικη συνθεση παρακεταμολης υπο μορφη τροχισκων ή παστιλιων με βελτιωτικο γευσης συμβατο με την παρακεταμολη

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4269835A (en) * 1979-12-13 1981-05-26 Whittle Barry J Nasal composition for relieving nasal distress
US4639459A (en) * 1983-02-01 1987-01-27 Burroughs Wellcome Co. Use of trifluoromethyl compounds
US4642231A (en) * 1983-07-20 1987-02-10 Warner-Lambert Company Magnesium trisilicate suitable for preparation of medicament adsorbates of antihistamines
US5025019A (en) * 1984-04-09 1991-06-18 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
US6077822A (en) * 1993-09-14 2000-06-20 Dumex-Alpharma A/S Drug salts
US6596298B2 (en) * 1998-09-25 2003-07-22 Warner-Lambert Company Fast dissolving orally comsumable films
AR025110A1 (es) * 1999-08-13 2002-11-06 Vela Pharmaceuticals Inc Metodos y composiciones para tratar o prevenir alteraciones del sueno y enfermedades asociadas usando dosis muy bajas de ciclobenzaprina
CA2440588C (en) * 2001-03-13 2010-02-09 Penwest Pharmaceuticals Co. Chronotherapeutic dosage forms
US6827946B2 (en) * 2001-12-05 2004-12-07 Collegium Pharmaceutical, Inc. Compositions containing both sedative and non-sedative antihistamines

Also Published As

Publication number Publication date
AU2002350897B2 (en) 2008-12-11
AU2002313364B2 (en) 2004-02-19
GB0228045D0 (en) 2003-01-08
WO2003047580A1 (en) 2003-06-12
CN1617723A (zh) 2005-05-18
EP1455786A1 (en) 2004-09-15
US20070015800A1 (en) 2007-01-18
GB0128674D0 (en) 2002-01-23
US20030134878A1 (en) 2003-07-17
GB0227708D0 (en) 2003-01-08
CA2468044A1 (en) 2003-06-12
GB2383537A (en) 2003-07-02
RU2004119832A (ru) 2005-04-20
US20040029927A1 (en) 2004-02-12
PL370258A1 (en) 2005-05-16
RU2320340C2 (ru) 2008-03-27
AU2002350897A1 (en) 2003-06-17
JP2005515200A (ja) 2005-05-26
GB2383537B (en) 2003-12-10
US20050282869A1 (en) 2005-12-22
IL162146A0 (en) 2005-11-20
ZA200404172B (en) 2005-09-01

Similar Documents

Publication Publication Date Title
GB0312419D0 (en) Use of a compound in the treatment of sleep disorders and the like, in providing refreshedness on waking and a method for the treatment of grogginess
EP1509279A4 (en) DEVICE AND METHOD FOR THE TREATMENT OF HEART DISEASES
DE60116066D1 (de) Titanium mit verminderter anfälligkeit für verfärbung in der atmosphäre und herstellungsverfahren dafür
EP1360965A4 (en) METHOD FOR THE TREATMENT OF DISEASES ASSOCIATED WITH A DECREASE OF THE EXPOSURE OF THE AOP-1 GENE OR AOP-1 AND MEANS FOR THE TREATMENT OF THE DISEASES
HK1079203A1 (en) Substituted amine derivatives and methods of use in the treatment of angiogenesis related disorders
ZA200504724B (en) Pregabalin derivatives for the treatment of fibromyalgia and other disorders
MXPA03007960A (es) Compuestos y metodos para el tratamiento de desordenes urogenitales.
EP1416961A4 (en) COMPOSITION AND METHOD FOR THE TREATMENT OF A DISEASE
AU2003286567A8 (en) Methods for the treatment of skin disorders
NO20041588L (no) Anvendelse av flibanserin ved behandling av seksuelle forstyrrelser
NO20035611D0 (no) Sammensetning og fremgangsmåte for kontroll ved behandling av hydrokarbon
NO20032636D0 (no) 3-indolinderivater som er nyttige i behandlingen av psykiatriske og nevrologiske forstyrrelser
NO20052698D0 (no) 4(fenylpiperazinyl-metyl)benzamid-derivater og deres anvendelse ved behandling av smerte og gasatrintestinale lidelser.
NO20052699D0 (no) 4(fenylpiperazinyl-metyl)benzamid-derivater og deres anvendelse ved behandling av smerte og gastrointestinale lidelser.
EP1642592A4 (en) MEANS FOR THE TREATMENT OF SARCOIDOSIS AND TREATMENT METHOD THEREFOR
NO20042389L (no) Anvendelse av en forbindelse ved behandling av sovnforstyrrelser og lignende ved a skaffe til veie utvilthet ved oppvakning og en fremgangsmate for behandling av omtakethet som er forbundet med dette
NO20034300L (no) Nye cyano-substituerte dihydropyrimidinforbindelser og anvendelse for behandling av sykdommer
AU2001251306A1 (en) Treatment of sleep disorders with hypocretin-1
AU2002313364A1 (en) Use of a compound in providing refreshedness on waking and a method for the treatment of drowsiness therewith
AU2003259246A8 (en) Methods for the use of neurotoxin in the treatment of urologic disorders
DE60117122D1 (de) Verwendung von mirtazapin zur behandlung von schlafstörungen
AU2003266965A1 (en) Use of carboxamides for the treatment of tinnitus
EP1539100A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF SKIN DISORDERS
PL377520A1 (pl) Pochodne pregabaliny przeznaczone do leczenia fibromialgii i innych zaburzeń
EP1371371A4 (en) USE OF N-ACETYL-D-GLUCOSAMINE IN THE PRODUCTION OF A PHARMACEUTICAL AGENT FOR THE PREVENTION AND TREATMENT OF SEXUAL DISORDERS

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application